• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Sangamo Biosciences Inc. (SGMO)

    -NasdaqGS
    9.97 Down 0.19(1.87%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.7
    Mean Recommendation (last week):1.7
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:22.00
    Median Target:22.00
    High Target:30.00
    Low Target:17.00
    No. of Brokers:5

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    May 3, 2013BioLogic Equity ResearchInitiated Sell
    Oct 19, 2009Brean MurrayInitiated Sell
    Apr 14, 2009Cantor FitzgeraldDowngradeBuyHold
    Feb 5, 2009Merriman Curhan FordUpgradeNeutralBuy
    Nov 11, 2008Piper JaffrayDowngradeBuySell
    Nov 11, 2008Merriman Curhan FordDowngradeBuyNeutral
    Oct 16, 2008Merriman Curhan FordInitiated Buy
    May 29, 2008Brean MurrayInitiated Sell
    Oct 17, 2007Pacific Growth EquitiesInitiated Buy
    Jul 26, 2007Rodman & RenshawDowngradeMkt OutperformMkt Perform

    More Upgrades & Downgrades for SGMO

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222
    Buy5433
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.